Belgium· BE-AMP-SAM137873-00
Grafalon 20 mg/ml
A antithymocyte immunoglobulin (rabbit) product containing anti-t lymphocyte rabbit immunoglobulin for human use, registered in Belgium by Neovii Biotech. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Antithymocyte immunoglobulin (rabbit) is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AA04 (antithymocyte immunoglobulin (rabbit)), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Antithymocyte immunoglobulin (rabbit) · ATC L04AA04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Anti-T Lymphocyte Rabbit Immunoglobulin for Human Use
- Manufacturer
- Neovii Biotech
- Country
- Belgium (BE)
- ATC code
- L04AA04
- ATC class
- Antithymocyte immunoglobulin (rabbit)
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0730325
- be_apb0600197
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L04AA04
Antithymocyte immunoglobulin (rabbit), as other registers publish it.
- SwitzerlandGrafalon
- PolandGrafalonNeovii Biotech GmbH
- NorwayGrafalonNeovii Biotech
- SwitzerlandGrafalon
- CzechiaGRAFALONNeovii Biotech GmbH, Gräfelfing
- CzechiaGRAFALONNeovii Biotech GmbH, Gräfelfing
- United KingdomGrafalon 100mg/5ml concentrate for solution for infusion vialsImported (Germany)
- NetherlandsGrafalon 20 mg/ml concentraat voor oplossing voor infusieNeovii Biotech GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/729f5f95-4837-42ab-b8e0-975931a4e4b1 GET /v1/drugs/729f5f95-4837-42ab-b8e0-975931a4e4b1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Grafalon 20 mg/ml",
"name_fr": "Grafalon 20 mg/ml",
"name_nl": "Grafalon 20 mg/ml",
"amp_code": "SAM137873-00",
"strengths": [
"20.0000",
"1.5600"
],
"pack_count": 1,
"substances": [
"Anti-T Lymphocyte Rabbit Immunoglobulin for Human Use",
"Sodium Dihydrogen Phosphate Dihydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Antithymocyte Immunoglobulin (Rabbit)",
"authorisation_numbers": [
"BE137873"
]
}See everything about antithymocyte immunoglobulin (rabbit).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.